SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-19-000223
Filing Date
2019-02-14
Accepted
2019-02-14 16:36:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A t2biosystems_13gam2dec312018.htm SC 13G/A 46860
  Complete submission text file 0000905718-19-000223.txt   48354
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 19607266
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019 212-309-7664
Lagoda Investment Management, L.P. (Filed by) CIK: 0001632108 (see all company filings)

IRS No.: 464740139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A